New DAA guidelines could facilitate outsourcing, says DoseAid


Dose Administration Aids

As of December 7, the Pharmacy Board of Australia’s revised guidelines will clarify that it is the pharmacist’s prerogative as to whether further checking of a DAA is required.

The new guidelines state that, if utilising third party packed DAAs, the supplying pharmacist ‘must make an assessment of the measures, techniques and technology used by the packing pharmacist at the third party packing facility to check packed DAAs for accuracy, to determine whether additional checking of a DAA is required prior to its supply to a patient or their agent’.

According to DoseAid, as our ageing population grows, so does the demand for DAAs to help people  manage their medications.

With this increased demand looming, pharmacies across Australia are considering the merits of outsourcing their DAA packing requirements, the company says.

In the past, the perceived need to check DAAs upon their return to the pharmacy – an often laborious and costly task – had been a deterrent, it says.

National Manager of DoseAid Seth Grantley says, “Choosing to partner with a Therapeutic Goods Administration licensed operation, like DoseAid, that follows Good Manufacturing Practice  standards and processes, should ease the mind of pharmacists with respect to re-checking the sachets.

“We would encourage our customers to learn as much about our state-of-the-art technology and processes as they can, so they feel comfortable leveraging the changes in the guidelines.”

The funding increase for DAAs as part of the Sixth Community Pharmacy Agreement earlier this year also reinforced the important role DAAs play in community healthcare.

EBOS General Manager, Group Business Development, Stuart Spencer, says the 6CPA funding and revised guidelines has reaffirmed the value of DoseAid’s offering.

“DoseAid was always positioned to help pharmacists cope with a changing landscape. It helps them form stronger relationships with their customers by providing a service that enhances medication adherence,” Spencer says.

“It is pleasing that both the Government and the Guild have recognised the role that DAAs can play in this regard.”

He says DoseAid has invested in technology and processes in line with GMP standards so its customers did not have to invest in infrastructure or labour to meet the growing DAA demand.

“The grey area around the need to check sachets always complicated the decision about whether to outsource this process so, with the new guidelines as at December 7, pharmacists should now be able to make this decision with greater clarity,” he says.

Previous Pharmacy leaflets have 'untapped potential,' say US researchers
Next National Medicines Symposium to discuss QUM, technology

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.